4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow NVC-422: new trials by email Literature Review of NVC-422 trials Research Report on NVC-422
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis Auriclosene Solution 0.3%, Auriclosene Vehicle - Bacterial Conjunctivitis | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 217 | 2013-06-01 | 2015-05-28 |
| Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation NVC-422, 0.2%, Sterile normal saline, 0.9% - Urinary Catheter Blockage and Encrustation | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 67 | 2010-11-01 | 2014-08-07 |
| Safety and Efficacy of Topical NVC-422 Gel in Impetigo NVC-422 - Impetigo | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 129 | 2009-08-01 | 2011-06-07 |
| Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate - Asymptomatic Bacteriuria | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 20 | 2008-10-01 | 2011-09-12 |
Bacteriuria (1) · Conjunctivitis (1) · Conjunctivitis, Bacterial (1) · Impetigo (1) · Spinal Cord Injuries (1)
NovaBay Pharmaceuticals, Inc. (4)
United States (3) · Dominican Republic (1)
Kenneth D. Krantz, MD, PhD (2) · Daisy M. Blanco, MD (1) · David W. Stroman, Ph.D. (1) · Rabih O. Darouiche, M.D. (1)